Trial NCT01518153

View at ClinicalTrials.gov 
Org. Study IDs: 2011-1104
Secondary IDs: NCI-2012-00131

Last trial update was posted on 2016-03-17

MeSH Interventions

Alemtuzumab Fludarabine Fludarabine phosphate Melphalan Methotrexate Tacrolimus

MeSH Conditions

Myeloproliferative Disorders

Other Conditions

Leukemia Lymphoma Myeloma Myeloproliferative Diseases

Stopping Reasons

Objectives not met.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID